Loading...
OTCM
TINLY
Market cap2.00bUSD
Oct 06, Last price  
10.45USD
1D
0.00%
Jan 2017
-48.22%
Name

Teijin Ltd

Chart & performance

D1W1MN
OTCM:TINLY chart
P/E
—
P/S
0.36
EPS
—
Div yield, %
1.54%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
0.86%
Revenues
873.19b
-13.16%
1,009,586,000,0001,036,623,000,000943,409,000,000765,840,000,000815,655,000,000854,370,000,000745,712,000,000784,424,000,000786,171,000,000790,748,000,000741,291,000,000834,986,000,000888,589,000,000853,746,000,000836,512,000,000926,054,000,0001,018,751,000,000960,459,000,0001,005,471,000,000873,190,000,000
Net income
-88.00b
L
34,124,000,00012,612,000,000-42,963,000,000-35,683,000,00025,182,000,00011,979,000,000-29,130,000,0008,356,000,000-8,086,000,00031,090,000,00050,133,000,00045,556,000,00045,057,000,00025,253,000,000-6,661,000,00023,158,000,000-17,695,000,000-11,712,000,00028,348,000,000-88,004,000,000
CFO
98.65b
+41.25%
96,455,000,00053,739,000,00040,391,000,00080,432,000,00077,132,000,00053,668,000,00064,305,000,00038,586,000,00076,030,000,00080,640,000,00079,040,000,00080,092,000,00080,899,000,00094,214,000,000107,729,000,00089,656,000,00055,086,000,00080,595,000,00069,843,000,00098,654,000,000
Dividend
Sep 29, 20260.16051 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Teijin Limited, a global enterprise established in Tokyo, Japan, in 1918, operates across multiple key sectors including fibers, films, composites, healthcare, and IT. The company's advanced materials portfolio encompasses various fibers such as aramid, carbon, and polyester, alongside specialized films like polycarbonate and high-density polyethylene. It also produces resins, molded parts, and additives, as well as lightweight glass and carbon fiber reinforced composites, particularly for automotive applications. In the healthcare domain, Teijin develops pharmaceuticals addressing a range of conditions, including bone and joint, respiratory, and cardiovascular diseases. It further provides medical devices for home oxygen therapy, non-invasive ventilation, rehabilitation, and sleep disorders, complemented by orthopedic implants and functional food ingredients. Beyond materials and healthcare, Teijin offers IT solutions like Recopic, an RFID technology for inventory management. The company also leverages its engineering expertise to address global issues such as environmental pollution, energy supply stability, and challenges associated with an aging workforce population.

Related entities

Subsidiaries (3)
Teijin Carbon Europe GmbH
Teijin Holdings Europe B.V.
Teijin Aramid B.V.

Key people

Naohiko Moriyama
Chief Financial Officer, Senior Managing Executive Officer, Representative Director · since 2024
Eiji Ogawa
Senior Managing Executive Officer of Teijin Group · since 2024
Noboru Yamanishi
Managing Executive Officer, Director · since 2023
Masataka Akiyoshi
Executive Officer of Teijin Group, Chief Director of Composite Molding Materials Business · since 2024
Noriko Higuchi
Executive Officer of Teijin Group, Chief Director of New Corporate Business · since 2024
Yasunari Hirata
Executive Officer of Teijin Group, Chief Director of Healthcare Business, President of Subsidiary · since 2024
Peter Horst
Executive Officer of Teijin Group, Chief Director of Aramid, President of Subsidiary · since 2024
Tsutomu Igawa
Executive Officer of Teijin Group · since 2024
Shukei Inui
Executive Officer of Teijin Group, Chief Director of Carbon Fiber Business · since 2024
Junji Kitahama
Executive Officer of Teijin Group, Chief Director of Resins Business · since 2024
Yasuhiko Kuriyama
Executive Officer of Teijin Group · since 2024
Fumiaki Sakurai
Executive Officer of Teijin Group · since 2024
Masato Tanaka
Executive Officer of Teijin Group · since 2024
Masaki Taneda
Executive Officer of Teijin Group, Chief Director of Healthcare Business, President of Subsidiary · since 2024
Akimoto Uchikawa
Executive President, Chief Executive Officer, Representative Director · since 2022
Reiko Kusunose
Independent Director · since 2024
Tamie Minami
Independent Director · since 2023
Masaru Onishi
Independent Director · since 2019
Independent Director · since 2022
IPO date
May 16, 1949
Employees
22,484
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
中之島三丁目2番4号
大阪府 大阪市北区 530-8605
JP
Address
2-4, Nakanoshima 3-chome
Kita-ku Osaka 530-8605
JP
Other language
TEIJIN LIMITED

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT